# Arcutis Biotherapeutics (stock symbol: ARQT) Logo in transparent PNG and SVG formats

## Arcutis Biotherapeutics Logo large

### Arcutis Biotherapeutics Logo large Download PNG (25.71 KB)

![Arcutis Biotherapeutics Logo large Download PNG (25.71 KB)](/img/orig/ARQT_BIG-a5028e42.png)

### Arcutis Biotherapeutics Logo large Download SVG (19.79 KB)

![Arcutis Biotherapeutics Logo large Download SVG (19.79 KB)](/img/orig/ARQT_BIG-b72e40bb.svg)

## Arcutis Biotherapeutics Logo icon format

### Arcutis Biotherapeutics Logo icon format Download PNG (31.64 KB)

![Arcutis Biotherapeutics Logo icon format Download PNG (31.64 KB)](/img/orig/ARQT-3624c144.png)

### Arcutis Biotherapeutics Logo icon format Download SVG (1.49 KB)

![Arcutis Biotherapeutics Logo icon format Download SVG (1.49 KB)](/img/orig/ARQT-c6917c15.svg)

## Arcutis Biotherapeutics Logo large for dark backgrounds

### Arcutis Biotherapeutics Logo large for dark backgrounds Download PNG (15.44 KB)

![Arcutis Biotherapeutics Logo large for dark backgrounds Download PNG (15.44 KB)](/img/orig/ARQT_BIG.D-a18a1328.png)

### Arcutis Biotherapeutics Logo large for dark backgrounds Download SVG (19.69 KB)

![Arcutis Biotherapeutics Logo large for dark backgrounds Download SVG (19.69 KB)](/img/orig/ARQT_BIG.D-3e53679b.svg)

## Arcutis Biotherapeutics Logo icon format for dark backgrounds

### Arcutis Biotherapeutics Logo icon format for dark backgrounds Download PNG (18.63 KB)

![Arcutis Biotherapeutics Logo icon format for dark backgrounds Download PNG (18.63 KB)](/img/orig/ARQT.D-c7b7b7a6.png)

### Arcutis Biotherapeutics Logo icon format for dark backgrounds Download SVG (1.42 KB)

![Arcutis Biotherapeutics Logo icon format for dark backgrounds Download SVG (1.42 KB)](/img/orig/ARQT.D-0b45a910.svg)

## About Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

1. Website domain: arcutis.com
2. Employees: 147
3. Marketcap: $0.84 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
